Department of Cardiology, Erasmus MC, 3015 GD Rotterdam, The Netherlands.
Sensors (Basel). 2021 May 28;21(11):3763. doi: 10.3390/s21113763.
The management of heart failure remains challenging despite evidence-based medical and pharmacological advances, especially in the ambulatory setting. There is an urgent need to develop strategies to reduce hospitalizations and readmission rates due to heart failure. Frequent monitoring of high-risk patients is imperative, and with the development of wireless and remote technology, frequent monitoring is now possible via remote monitoring. Nowadays, remote management of patients with cardiac implantable electronic devices is being increasingly adopted and integrated into clinical practice. Several clinical trials studied the impact of remote monitoring on clinical outcomes in patients with implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization defibrillators (CRT-Ds). This point of view will focus on the remote monitoring of ICDs and CRT-Ds in patients with heart failure and discusses whether remote monitoring can be used as a potential instrument for the early identification of patients at risk of worsening heart failure.
尽管在循证医学和药理学方面取得了进展,但心力衰竭的管理仍然具有挑战性,尤其是在门诊环境中。迫切需要制定策略来降低因心力衰竭导致的住院和再入院率。对高危患者进行频繁监测至关重要,随着无线和远程技术的发展,现在可以通过远程监测进行频繁监测。如今,对植入式心脏电子设备患者的远程管理越来越多地被采用并整合到临床实践中。几项临床试验研究了远程监测对植入式心脏除颤器 (ICD) 和心脏再同步除颤器 (CRT-D) 患者临床结局的影响。本观点将重点关注心力衰竭患者的 ICD 和 CRT-D 远程监测,并讨论远程监测是否可作为早期识别心力衰竭恶化风险患者的潜在手段。